Tory and Labour MP team up to fight for psilocybin rescheduling and further research
A Conservative and a Labour MP have written a joint letter to all MPs urging the rescheduling of psilocybin and other psychedelics in the UK. The move comes after the two MPs addressed the issue in Prime Minister’s Questions (PMQs). Crispin Blunt, the Chair of the Conservative Drug Policy Reform Group (CDPRG), and Labour MP […]
Global coalition launches initiative to secure the rescheduling of psilocybin
A new initiative has been established to help push global decision-makers to reschedule psilocybin to grant access to those that could benefit from the potential therapeutic properties of the compound. The International Therapeutic Psilocybin Rescheduling Initiative (ITPRI) launched today. The ITPRI is a global coalition working to promote and secure a rescheduling of psilocybin under […]
‘Magic mushrooms’ a safe treatment for depression, King’s College researchers found
A new British study shows that administering psilocybin can be a valid option in treating drug-resistant depression. Researchers at the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King’s College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six […]
Another blow to the psychedelic industry’s attempts to use LSD for therapeutic purposes
The plans to test LSD in anxiety patients in a clinical study have been stopped in their tracks as the US Food and Drug Administration (FDA) has halted the process for unclear reasons. According to Reuters, the US FDA has put a clinical hold on Mind Medicine Inc’s application to start testing psychedelic drugs, such […]
Study on how ‘magic mushrooms’ affect frontline healthcare workers given green light
A study that will examine how psychedelics, combined with psychotherapy, could affect the mental health of frontline workers, starts soon, making it one of the first studies of its kind. According to a report in MedPage Today, the Food and Drug Administration (FDA) in the US has given the green light for the randomised trial. […]
‘Microdosing’ of psychedelics on the rise during the pandemic
More people have been ‘microdosing’ psychedelic drugs to improve their wellness and mental health during the pandemic, according to a recent survey. Microdosing refers to the practice of taking tiny doses of a drug – usually psychedelics such as psilocybin (magic mushrooms) and LSD. The Global Drug Survey, an independent research company based in London, […]
What did we learn from the largest psilocybin trial?
While the use of psychedelics and the development of psychedelic-based medicines and therapies are on the rise, evidence around how they work and affect us is still relatively under-researched, thanks to decades of prohibition. However, the recent publication of the results from the largest psilocybin study ever completed may help us to better understand the […]
How long do ‘magic mushrooms’ stay in your system?
As psychedelics are having their “renaissance” and even their medical use is becoming ever more accepted worldwide, we wondered: how long do ‘magic mushrooms’ stay in our system? It must be noted that many psychedelics, such as LSD and “magic mushrooms”, are currently graded as a Class A drug according to the Misuse of Drugs […]
Psilocybin could soon be legal in the UK – But what is it?
Boris Johnson recently announced that his government would be considering the possibility of re-scheduling psilocybin, effectively legalising its medical use. This policy change would place the UK alongside a number of other jurisdictions around the world that have, or are considering, legalising the substance. However, there are many who may not have heard of psilocybin […]
Boris Johnson to consider the legalisation of psilocybin
The UK’s Prime Minister Boris Johnson has announced that he will examine the latest advice and consider the increasing calls to legalise the psychedelic drug psilocybin. The news comes after a recent report by Conservative MP leader and Chairman of the Conservative Drug Policy Reform Group (CDPRG), Crispin Blunt, that Johnson had approved the proposed […]